1. Hydrophobic IR-780 Dye Encapsulated in cRGD-Conjugated Solid Lipid Nanoparticles for NIR Imaging-Guided Photothermal Therapy
    Ye Kuang et al, 2017, ACS Appl. Mater. Interfaces CrossRef
  2. Gene Delivery Potential of Biofunctional Carbonate Apatite Nanoparticles in Lungs
    Suleiman Yusuf Alhaji et al, 2014, BioMed Research International CrossRef
  3. null
    Ye Kuang et al, 2017 CrossRef
  4. Solid matrix-based lipid nanoplatforms as carriers for combinational therapeutics in cancer
    Biki Gupta et al, 2017, Journal of Pharmaceutical Investigation CrossRef
  5. Evaluation of Efficiency of Modified Polypropylenimine (PPI) with Alkyl Chains as Non-viral Vectors Used in Co-delivery of Doxorubicin and TRAIL Plasmid
    Mahboubeh Ebrahimian et al, 2017, AAPS PharmSciTech CrossRef
  6. null
    Narsireddy Amreddy et al, 2017 CrossRef
  7. Cisplatin and paclitaxel co-delivered by folate-decorated lipid carriers for the treatment of head and neck cancer
    Jiying Yang et al, 2017, Drug Delivery CrossRef
  8. null
    Sanjeeb Sahoo et al, 2018 CrossRef
  9. null
    Ye Kuang et al, 2018 CrossRef
  10. RNAi-based therapeutics for lung cancer: biomarkers, microRNAs, and nanocarriers
    Mariana Magalhães et al, 2018, Expert Opinion on Drug Delivery CrossRef
  11. Insight into pulmonary drug delivery: Mechanism of drug deposition to device characterization and regulatory requirements
    Nagarjun Rangaraj et al, 2018, Pulmonary Pharmacology & Therapeutics CrossRef
  12. Surface-tailored anti-HER2/neu-solid lipid nanoparticles for site-specific targeting MCF-7 and BT-474 breast cancer cells
    Eliana B. Souto et al, 2018, European Journal of Pharmaceutical Sciences CrossRef
  13. Increasing complexity and interactions of oxidative stress in chronic respiratory diseases: An emerging need for novel drug delivery systems
    Kamal Dua et al, 2018, Chemico-Biological Interactions CrossRef
  14. null
    Hadeer M. Abdelaziz et al, 2019 CrossRef
  15. Threatening cancer with nanoparticle aided combination oncotherapy
    Shruti Rawal et al, 2019, Journal of Controlled Release CrossRef
  16. null
    Josef Jampílek et al, 2019 CrossRef
  17. Co-delivery of drugs and plasmid DNA for cancer therapy
    Pei Yun Teo et al, 2016, Advanced Drug Delivery Reviews CrossRef
  18. Nanocarrier-mediated co-delivery systems for lung cancer therapy: recent developments and prospects
    Muhammad Asim Farooq et al, 2019, Environ Chem Lett CrossRef
  19. Nanocarrier-based systems for targeted and site specific therapeutic delivery
    Joydeb Majumder et al, 2019, Advanced Drug Delivery Reviews CrossRef
  20. Nano-Co-Delivery of Berberine and Anticancer Drug Using PLGA Nanoparticles: Exploration of Better Anticancer Activity and In Vivo Kinetics
    Iliyas Khan et al, 2019, Pharm Res CrossRef
  21. In vitro and in vivo evaluation of therapy targeting epithelial-cell adhesion-molecule aptamers for non-small cell lung cancer
    Mona Alibolandi et al, 2015, Journal of Controlled Release CrossRef
  22. Targeted nanoparticles for colorectal cancer
    Bruno A Cisterna et al, 2016, Nanomedicine CrossRef
  23. Applications of lipid nanoparticles in gene therapy
    Ana del Pozo-Rodríguez et al, 2016, European Journal of Pharmaceutics and Biopharmaceutics CrossRef
  24. Combinatorial therapeutic approaches with RNAi and anticancer drugs using nanodrug delivery systems
    Anish Babu et al, 2017, Drug Development and Industrial Pharmacy CrossRef
  25. null
    Harsh A. Joshi et al, 2019 CrossRef
  26. Gelatin Methacryloyl Hydrogels Control the Localized Delivery of Albumin-Bound Paclitaxel
    Margaux Vigata et al, 2020, Polymers CrossRef

  27. Hyaluronic Acid Capped, Irinotecan and Gene Co-Loaded Lipid-Polymer Hybrid Nanocarrier-Based Combination Therapy Platform for Colorectal Cancer


    Zhiyu Wang et al, 2020, DDDT CrossRef
  28. null
    Simone Pinto Carneiro et al, 2020 CrossRef
  29. null
    Parijat Pandey et al, 2020 CrossRef
  30. null
    Keshav Raj Paudel et al, 2020 CrossRef
  31. null
    Sanyog Jain et al, 2021 CrossRef
  32. A Cationic Stearamide‐based Solid Lipid Nanoparticle for Delivering Yamanaka Factors: Evaluation of the Transfection Efficiency
    Funda Alkan et al, 2020, ChemistryOpen CrossRef
  33. Recent advances in co-delivery nanosystems for synergistic action in cancer treatment
    Bruna G. Carvalho et al, 2021, J. Mater. Chem. B CrossRef
  34. Understanding the implications of co-delivering therapeutic agents in a nanocarrier to combat multidrug resistance (MDR) in breast cancer
    Aditi Fulfager et al, 2021, Journal of Drug Delivery Science and Technology CrossRef
  35. null
    Mayank Handa et al, 2022 CrossRef
  36. Glimpse into the Cellular Internalization and Intracellular Trafficking of Lipid- Based Nanoparticles in Cancer Cells
    Elham Kamal Kazemi et al, 2022, ACAMC CrossRef
  37. Nanoparticles design considerations to co-deliver nucleic acids and anti-cancer drugs for chemoresistance reversal
    Sahar Eljack et al, 2022, International Journal of Pharmaceutics: X CrossRef
  38. Lipid Nanocarrier-Based Drug Delivery Systems: Therapeutic Advances in the Treatment of Lung Cancer
    So-Jung Kim et al, 2023, IJN CrossRef
  39. null
    Ümmühan Fulden Aydın et al, 2023 CrossRef
  40. null
    Apurba Gouri et al, 2024 CrossRef
  41. Adjuvant Novel Nanocarrier-Based Targeted Therapy for Lung Cancer
    Kangkan Sarma et al, 2024, Molecules CrossRef
  42. Lipid Nanoparticles in Lung Cancer Therapy
    Hossein Omidian et al, 2024, Pharmaceutics CrossRef
  43. Better together: nanoscale co-delivery systems of therapeutic agents for high-performance cancer therapy
    Liyan Sun et al, 2024, Front. Pharmacol. CrossRef
  44. Solid Lipid Nanoparticles for Pulmonary Delivery of Biopharmaceuticals: A Review of Opportunities, Challenges, and Delivery Applications
    Saniya Alwani et al, 2024, Mol. Pharmaceutics CrossRef